The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Stengone Carmine N. since 2024.
This trader's CIK number is 1861519.
At the time of last reporting, Stengone Carmine N. was the CEO and President of Contineum Therapeutics, Inc.. (stock ticker symbol CTNM).
Also see all insider trading activities at Contineum Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | KPRX | 1,250 | $4,600 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | CTNM | 0 | $0 | 400 | $6,400 | 400 | $504 |
1. Kiora Pharmaceuticals Inc (KPRX)
2. Contineum Therapeutics, Inc. (CTNM)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-09-11 | KPRX | Buy | 1,250 | 3.68 | 4,600 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-02-11 | CTNM | Sale | 400 | 16.00 | 6,400 |
| 2026-02-11 | CTNM | Option Ex | 400 | 1.26 | 504 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Stengone Carmine N. (CEO and President of Contineum Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.